NEW YORK, Oct. 11, 2012 \/PRNewswire\/ — Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
http:\/\/www.reportlinker.com\/p01009666\/Global-Markets-for-Treatments-for-Syndromes-of-Dementia-and-Movement-Disorders.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology<\/a> <\/p>\n INTRODUCTION <\/p>\n This report explores present and future strategies within the neurodegenerative disorder market, which includes treatments and therapies for progressive dementia, progressive dementia with other neurological abnormalities and movement disorders. Market gains, setbacks and needs are discussed in this report. Comparisons, usage and the advantages and disadvantages of different types of technologies, including small molecules and monoclonal antibodies, are also presented in this report. <\/p>\n A detailed analysis of the structure of the syndromes of dementia and movement disorder industry has been conducted. Revenues are broken down by neurodegenerative disease and primary clinical\/pathological feature. Sales figures are estimated for the five-year period from 2012 through 2017. <\/p>\n Applications for syndromes of dementia and movement disorder treatments, or therapeutic technologies, are also discussed separately in the report, with an emphasis on small molecule and monoclonal antibodies technology. The report also covers significant patents and their allotment in each category. <\/p>\n R&D spending, along with increasing competition, patent expiries and new technologies are taking the market in a new direction. Global market revenues increased from 2009 to 2011 and are expected to continue to show growth over the forecast period as new advances, launches and collaborations continue to influence the market. This study looks at most of the systems affected by these factors. <\/p>\n Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type of technology in light of the new technologies, growing competition and changing customer needs. <\/p>\n Some of her other reports with BCC include Reagents for Chromatography; SpectroscopyAn Enduring Market; Advanced Drug Delivery SystemsTechnologies and Global Markets; Orthopedic Drugs, Implants and DevicesMedical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory IndustryThe Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and PackagingGlobal Markets; Chiral TechnologyGlobal Markets; Autacoids and Related DrugsTechnologies and Global Markets; ContraceptivesTechnologies and Global Markets; Liver Disease TreatmentsThe Global Market; Hormone Replacement Therapies and Other Hormone TherapiesGlobal Markets; Cardiovascular MedicineDiagnostics, Drugs and Devices; and Cancer Therapies ? Technologies and Global Markets. <\/p>\n The lead consultant on this project is Ms. Ruma Chakravarty, who holds a master’s degree in biophysics. She has tremendous experience in market research, quality, process improvement and lean and six sigma concepts. <\/p>\n<\/p>\n Continued here: Source: NEW YORK, Oct. 11, 2012 \/PRNewswire\/ — Reportlinker.com announces that a new market research report is available in its catalogue: http:\/\/www.reportlinker.com\/p01009666\/Global-Markets-for-Treatments-for-Syndromes-of-Dementia-and-Movement-Disorders.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology<\/a> INTRODUCTION This report explores present and future strategies within the neurodegenerative disorder market, which includes treatments and therapies for … Continue reading
\nGlobal Markets for Treatments for Syndromes of Dementia and Movement Disorders<\/a><\/p>\n
http:\/\/www.longevitymedicine.tv\/global-markets-for-treatments-for-syndromes-of-dementia-and-movement-disorders\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"